Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments

被引：28

作者：

Bieber, J

Kavanaugh, A

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Dept Med, Sch Med, La Jolla, CA 92037 USA

[2] Univ Calif San Diego, Ctr Innovat Therapy, Sch Med, La Jolla, CA 92093 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2004年 / 30卷 / 02期

关键词：

D O I：

10.1016/j.rdc.2004.01.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Evidence supports the association of tuberculosis (TB) with tumor necrosis factor inhibitor therapy in patients who have rheumatoid arthritis. There seem to be differential risks of TB with the currently available inhibitors. Screening for latent TB infection with purified protein derivative is indicated for patients who are being considered for treatment; it seems to be effective in reducing the occurrence of TB in treated patients.

引用

页码：257 / +

页数：15

共 67 条

[51] Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-α
Olleros, ML
Guler, R
Corazza, N
Vesin, D
Eugster, HP
Marchal, G
Chavarot, P
Mueller, C
Garcia, I
[J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3394 - 3401
[52] Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria
Ottenhoff, THM
Kumararatne, D
Casanova, JL
[J]. IMMUNOLOGY TODAY, 1998, 19 (11): : 491 - 494
[53] EXTRAPULMONARY TUBERCULOSIS IN THE UNITED-STATES
RIEDER, HL
SNIDER, DE
CAUTHEN, GM
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (02): : 347 - 351
[54] Secreted lymphotoxin-α is essential for the control of an intracellular bacterial infection
Roach, DR
Briscoe, H
Saunders, B
France, MP
Riminton, S
Britton, WJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 239 - 246
[55] Rojas M, 1999, J IMMUNOL, V162, P6122
[56] Benefits of screening for latent Mycobacterium tuberculosis infection
Rose, DN
[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) : 1513 - 1521
[57] Binding and functional comparisons of two types of tumor necrosis factor antagonists
Scallon, B
Cai, A
Solowski, N
Rosenberg, A
Song, XY
Shealy, D
Wagner, C
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) : 418 - 426
[58] Senaldi G, 1996, J IMMUNOL, V157, P5022
[59] Medical progress: Management of tuberculosis in the United States
Small, PM
Fujiwara, PI
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 189 - 200
[60] Tumor necrosis factor a blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue
Smeets, TJM
Kraan, MC
van Loon, ME
Tak, PP
[J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (08): : 2155 - 2162

← 1 2 3 4 5 6 7 →